Aurora cannabis introduces the company's first inhalable resin cartridges for patients in the united kingdom

Nasdaq | tsx: acb canada's leading medical cannabis company expands patient offering with innovative dosage solution edmonton, ab , april 15, 2025 /prnewswire/ - aurora cannabis inc. (nasdaq: acb) (tsx: acb), the canadian-based leading global medical cannabis company, has announced today the availability of medical cannabis concentrates to patients in the united kingdom (uk). this launch marks the company's meaningful step in offering its proprietary cultivar-specific inhalable cannabis extracts in the uk market.
ACB Ratings Summary
ACB Quant Ranking